
Yuanbao Inc.: financial statements
Price
$10.61
November 20, 2026Market cap $382M
What Ploutos Investor adds for Yuanbao
Part of Ploutos Investor, €9.99 a month
- The full history: 3 fiscal years, from 2023
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The reported profit is far larger than a business usually earns on its market value, which usually means one-off or accounting gains. We leave out the P/E and the earnings yield.
Financial statements
Each fiscal year's income statement, balance sheet and cash flow as the company filed them, and the latest quarters.
Click a line to see it on the chart.
Revenue
+47.3% a year over 2 years
| Line | 2023 | 2024 | 2025 | Average a year |
|---|---|---|---|---|
| Revenue | $288M | $450M | $625M | +47.3% |
| Cost of revenue | $19M | $23M | $24M | +11.0% |
| Gross profit | $269M | $427M | $601M | +49.6% |
| Operating income | $29M | $122M | $201M | +163.7% |
| Net income | $29M | $119M | $187M | +155.5% |
| Earnings per share | -$3.98 | $2.62 | $3.92 | |
| Earnings per share, basic | -$3.98 | $3.57 | $7.97 | |
| Margins | ||||
| Gross margin | 93.3% | 94.9% | 96.2% | |
| Operating margin | 10.0% | 27.1% | 32.2% | |
| Net margin | 9.9% | 26.4% | 29.9% | |
By segment
Revenue and operating income by business segment or by product, as the company itself reports them in each year's 10-K. Each year from the latest filing that carries it, so a segment renamed or re-cut shows in its current form.
- Marketing And Related Analytical Services
- Medical Insurance
- Critical Illness Insurance
- Other Shortduration Insurance Product Line
- Life Insurance And Other Long Term Insurance
- Long Term Insurance
- Service Other
- Other System Services
- Post Sale Support Services
- 2023: Marketing And Related Analytical Services $177M, Medical Insurance $71M, Critical Illness Insurance $23M, Other Shortduration Insurance Product Line $1.9M, Life Insurance And Other Long Term Insurance $4.2M, Long Term Insurance $4.2M, Service Other $1.8M, Other System Services $630.1K, Post Sale Support Services –
- 2024: Marketing And Related Analytical Services $293M, Medical Insurance $106M, Critical Illness Insurance $35M, Other Shortduration Insurance Product Line $4.3M, Life Insurance And Other Long Term Insurance –, Long Term Insurance $2.4M, Service Other $1.2M, Other System Services $43.4K, Post Sale Support Services $7.5M
- 2025: Marketing And Related Analytical Services $359M, Medical Insurance $146M, Critical Illness Insurance $57M, Other Shortduration Insurance Product Line $3.5M, Life Insurance And Other Long Term Insurance $850.7K, Long Term Insurance $850.7K, Service Other $512.8K, Other System Services $195.6K, Post Sale Support Services –
| Product | 2023 | 2024 | 2025 | Share 2025 |
|---|---|---|---|---|
| Marketing And Related Analytical Services | $177M | $293M | $359M | 63% |
| Medical Insurance | $71M | $106M | $146M | 26% |
| Critical Illness Insurance | $23M | $35M | $57M | 10% |
| Other Shortduration Insurance Product Line | $1.9M | $4.3M | $3.5M | 0.6% |
| Life Insurance And Other Long Term Insurance | $4.2M | – | $850.7K | 0.1% |
| Long Term Insurance | $4.2M | $2.4M | $850.7K | 0.1% |
| Service Other | $1.8M | $1.2M | $512.8K | 0.1% |
| Other System Services | $630.1K | $43.4K | $195.6K | 0.0% |
From the XBRL of 1 of the company's annual reports to the SEC (ASC 280). Amounts in dollars.
Amounts are in dollars as the company filed them in its annual reports (10-K or 20-F). Those reporting in another currency are converted at each fiscal year-end rate. Shares and earnings per share are adjusted for splits.
In some years the company reports no operating income, so we show pre-tax income.
Per-share figures are per quoted ADS, which stands for 6 of the company's ordinary shares; the filings count per ordinary share.
Debt and obligations
What the company owes beyond the loans on its balance sheet, and when it pays, from the notes to its annual report: debt maturities, leases, pension plans, goodwill by segment, and how it gets to the tax it pays.
Leases
Dec 31, 2025Operating leases
$7.9M
Finance leases
–
- Average discount rate
- 3.7%
- Lease cost for the year
- $14M
The liability is the present value of the rent still to pay, at December 31, 2025. It is not counted in the ladder's debt. The filing
Operating lease payments by year
From the statutory to the effective tax rate, 2025
Dec 31, 2025Statutory rate
25.0%
Effective rate
7.2%
The company paid 7.2% in tax on its profit, 17.8 points below the statutory rate it starts from (25.0%). Below, the reasons it gives.
The lines the company states do not reach its effective rate, so we do not show them. Both rates are the filing's. The filing
Effective tax rate by year
The metrics a company reports about itself (users, stores, subscribers) are read for S&P 500 companies only.
The full analysis
What do Yuanbao's filings show?
These are Yuanbao's figures from its filings. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
How much revenue did YB have in 2025?
Yuanbao had revenue of $625M and net income of $187M in fiscal 2025, a net margin of 29.9%.
How much debt does YB have?
On December 31, 2025 Yuanbao had total assets of $666M, debt of – and shareholders' equity of $479M.
How much free cash flow does YB have?
In fiscal 2025 Yuanbao had cash from operations of $214M and spent $2.7M on capital expenditure, leaving $211M of free cash flow.
Where are the figures from?
From Yuanbao Inc.'s annual and quarterly reports to the SEC, read from the structured data (XBRL) it files itself.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.